Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) - ICS-LABA; ADVATE (Global) - Antihaemophilic Factor (Recombinant); Adept (Global) - Icodextrin; Anoro Ellipta (Global) - LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) - ICS-LABA, and Incruse Ellipta (Global) - LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Generic Pharmaceuticals
- Sub-Industry: N/A
- Symbol: LON:VEC
- CUSIP: N/A
- Web: www.vectura.com
- Market Cap: £735.25 million
- Outstanding Shares: 677,654,000
- 50 Day Moving Avg: GBX 112.59
- 200 Day Moving Avg: GBX 130.96
- 52 Week Range: GBX 108 - GBX 166.97
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: £168.67 million
- Price / Sales: 4.36
- Book Value: GBX 1 per share
- Price / Book: 1.09
- EBIDTA: £48.27 million
- Net Margins: -25.67%
- Return on Equity: -7.89%
- Return on Assets: -6.32%
- Average Volume: 1.54 million shs.
Frequently Asked Questions for Vectura Group PLC (LON:VEC)
What is Vectura Group PLC's stock symbol?
Vectura Group PLC trades on the London Stock Exchange (LON) under the ticker symbol "VEC."
Where is Vectura Group PLC's stock going? Where will Vectura Group PLC's stock price be in 2017?
10 brokerages have issued 12 month price objectives for Vectura Group PLC's stock. Their forecasts range from GBX 160 to GBX 225. On average, they anticipate Vectura Group PLC's share price to reach GBX 210.13 in the next twelve months. View Analyst Ratings for Vectura Group PLC.
Who are some of Vectura Group PLC's key competitors?
Some companies that are related to Vectura Group PLC include Spire Healthcare Group PLC (SPI), Clinigen Group PLC (CLIN), TherapeuticsMD (TXMD), TherapeuticsMD (TXMD), Knight Therapeutics (GUD), Biohaven Pharmaceutical Holding Co Ltd (BHVN), Genus plc (GNS), National HealthCare (NHC), Asante Solutions (PUMP), ProMetic Life Sciences (PLI), Novadaq Technologies (NDQ), Canfor Pulp Products (CFX), Extendicare (EXE), CVS Group Plc (CVSG), Myovant Sciences Ltd (MYOV), Keryx Biopharmaceuticals (KERX), Advanced Medical Solutions Group plc (AMS) and Emis Group Plc (EMIS).
Who are Vectura Group PLC's key executives?
Vectura Group PLC's management team includes the folowing people:
- James Ward-Lilley, Chief Executive Officer, Executive Director
- Frank C. Condella Jr., Vice Chairman of the Board
- Andrew Derodra, Chief Financial Officer, Director
- Joanne Hombal, Director of Human Resources
- Roger Heerman, Chief Commercial Officer
- Karl David Keegan Ph.D., Chief Corporate Development Officer
- Bruno F. J. Angelici, Non-Executive Chairman of the Board
- Per-Olof Andersson, Non-Executive Director
- Thomas Werner, Non-Executive Director
- Susan Elizabeth Foden Ph.D., Senior Independent Non-Executive Director
How do I buy Vectura Group PLC stock?
Shares of Vectura Group PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Vectura Group PLC's stock price today?
MarketBeat Community Rating for Vectura Group PLC (LON VEC)MarketBeat's community ratings are surveys of what our community members think about Vectura Group PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Vectura Group PLC stock can currently be purchased for approximately GBX 108.50.
Consensus Ratings for Vectura Group PLC (LON:VEC) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 2 Hold Ratings, 7 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.60)|
|Consensus Price Target: ||GBX 210.13|
Analysts' Ratings History for Vectura Group PLC (LON:VEC)
(Data available from 8/21/2015 forward)
|8/16/2017||Shore Capital||Reiterated Rating||Buy|
|8/16/2017||Peel Hunt||Reiterated Rating||Hold||GBX 160|
|6/29/2017||Numis Securities Ltd||Reiterated Rating||Buy||GBX 214|
|6/29/2017||N+1 Singer||Reiterated Rating||Hold|
|5/12/2017||J P Morgan Chase & Co||Lower Price Target||Overweight||GBX 240 -> GBX 210|
|4/25/2017||Royal Bank Of Canada||Downgrade||Underperform|
|4/4/2017||Stifel Nicolaus||Reiterated Rating||Buy||GBX 225|
|3/30/2017||Citigroup Inc.||Reiterated Rating||Buy||GBX 225|
|3/21/2017||Investec||Reiterated Rating||Buy||GBX 220|
|11/29/2016||FinnCap||Reiterated Rating||Buy||GBX 225|
Earnings History for Vectura Group PLC (LON:VEC)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Vectura Group PLC (LON:VEC)
Current Year EPS Consensus Estimate: $4.72 EPS
Dividend History for Vectura Group PLC (LON:VEC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Vectura Group PLC (LON:VEC)Insider Trades by Quarter for Vectura Group PLC (LON:VEC)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/4/2017||Andrew Derodra||Insider||Buy||135||GBX 111||£149.85|
|6/6/2017||Andrew Derodra||Insider||Buy||135||GBX 111||£149.85|
|5/5/2017||Andrew Derodra||Insider||Buy||105||GBX 143||£150.15|
|4/6/2017||Andrew Derodra||Insider||Buy||99||GBX 152||£150.48|
|2/6/2017||Andrew Derodra||Insider||Buy||111||GBX 135||£149.85|
|9/30/2016||Andrew Derodra||Insider||Buy||30,000||GBX 138||£41,400|
|9/27/2016||Trevor Phillips||Insider||Sell||240,841||GBX 139||£334,768.99|
|9/26/2016||Bruno Angelici||Insider||Buy||80,000||GBX 143||£114,400|
|7/7/2015||Oakley,Andrew J.||Insider||Buy||1,000||GBX 180||£1,800|
|1/15/2015||Trevor Phillips||Insider||Sell||171,777||GBX 144.50||£248,217.77|
Headline Trends for Vectura Group PLC (LON:VEC)
Latest Headlines for Vectura Group PLC (LON:VEC)
Vectura Group PLC (VEC) Chart for Monday, August, 21, 2017